iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

计划入组 57 人 · 首次发布于 2017 年 11 月 22 日

The ctDNA-RECIST Trial Part One

计划入组 167 人 · 首次发布于 2024 年 8 月 20 日

Precise 3D Surview

计划入组 274 人 · 首次发布于 2025 年 12 月 5 日

Targeted Vanco-resist. Enterococcus (Pylum Biosciences)

CRISPR-Cas12 gene therapy (HG-PRECISE, hyperlipidemia)

CRISPR-Cas12 gene therapy (HG-PRECISE, Transthyretin Amyloidosis)

Adze Biotechnology Receives Ethics Approval for Phase I Oncolytic Immunotherapy Trial in Metastatic Melanoma

Beyond Cancer Receives Approval for Phase 1b Trial of LV-UNO with Anti-PD-1 Therapy in Solid Tumors

Novel Complement Factor H Antibody GT103 Shows Promise in Refractory Non-Small Cell Lung Cancer Trial